Legislation roundup: Data security, pharma antitrust and insurance investment in REITs

Data processors may not take biometric features as the sole method of authenticating individuals' identities. Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector. Insurance capital may invest in REITs.

3 minute readNovember 19, 2021 at 05:24 AM

Susan Mok

Cybersecurity

Cyberspace Administration of China, Regulations for the Administration of Cyber Data Security (Draft for Comments)

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)